Legal experts are indicating that a newly published case study examining talc-based powder’s role in malignant mesothelioma and other asbestos-related diseases may represent a sea change in the future of mesothelioma litigation. The study, which was recently published in the Journal of Occupational and Environmental Medicine, provides strong support for those who believe that their illnesses were cause by their use of such products as Johnson & Johnson’s Baby Powder, the company’s Shower to Shower product, and Colgate Palmolive’s Cashmere Bouquet body powder.
When people diagnosed with malignant mesothelioma or ovarian cancer believe that their illness was caused by asbestos in talc-based baby powders, they frequently call on expert witnesses to provide evidence supporting their claim. Among those who provide impressive testimony is Jacqueline Moline, a professor of occupational medicine, epidemiology and prevention at the Feinstein Institutes for Medical Research at Northwell Health. Professor Moline is the co-author of the new mesothelioma study.
According to Professor Moline’s research, an examination of the cases of 33 separate mesothelioma patients whose disease has been blamed on their use of asbestos-contaminated talc determined that each of them had no other exposure to asbestos. Yet all of them had a history of having used talcum powder. This research essentially eliminates any other causes of their disease.
Further strengthening the study’s importance is the fact that of the 33 mesothelioma patients whose cases were included, six had submitted tissue samples containing fibers of the type of asbestos found to contaminate asbestos talc. This asbestos differs from that used in commercial, industrial or construction settings. In many instances, defendants like Johnson & Johnson have argued that mesothelioma victims’ asbestos exposure must have come from another source, and this research contradicts that theory.
More research into talc powders’ role in mesothelioma will be conducted, but in the meantime mesothelioma victims need support and legal guidance. For more information, contact us at 1-800-966-2244.